YOKNEAM, Israel--(BUSINESS WIRE)--Syneron Dental Lasers (www.synerondental.com), the leading provider of innovative dental laser technologies announced today that it has signed a distribution ...

Syneron Dental has signed an OEM agreement with a European company to produce and distribute a dental laser using Syneron's Laser-in-Handpiece technology, according to the company. Details of the ...

Syneron Candela, the Nasdaq-listed vendor of laser-based medical and aesthetic devices, is set to be sold to private equity giant Apax Partners, in a cash deal valued at close to $400 million. The $46 ...

Private equity firm Apax Partners is continuing to keep the medical aesthetics market space hot with its proposed acquisition of Syneron Medical Ltd., also known as Syneron Candela, for $397 million.

Syneron to Acquire Assets of TransPharma Medical Ltd. YOKNEAM, ISRAEL--(Marketwire - March 12, 2012) - Syneron Medical Ltd. (NASDAQ: ELOS), the leading global aesthetic device company, announced today ...

IRVINE, Calif. and LONDON, April 3, 2017 /PRNewswire/ — Syneron Medical Ltd. (NASDAQ: ELOS), a leading global non-surgical aesthetic device company, and Apax Partners, a leading global private equity ...

Syneron will issue 6.7 mln shares to buy Candela Deal value represents 51 pct premium Deal expected to close by year end Candela shares up 36 pct Syneron stock down 11 pct (Adds analyst comment, ...

Apax Partners LLC has agreed to buy Syneron Medical Ltd. for $397 million in cash. Syneron Medical—also known as Syneron Candela—is based in Israel and maintains a U.S. headquarters in Irvine under ...

Syneron has been a serial disappointer, and a long position is a contrarian play with some risk. But there's legitimate progress in newer products, with sales seemingly solid and the SG&A line ...